81245 München, de
Thomas Stefan Schöberl
In just 50 trading days!
On November 11, 2013, after only 50 trading days, Leading-Invest's selection already showed its capabilities: the ten stocks, achieved a mean performance of +11%. Compared to the respective stock indices, six of the ten stocks performed much better than the index, the others barely below. The all the records beating DAX achieved 'only' +9% within the same time.
The portfolio's current top performer is Sixt from SDAX, with a spectacular plus of 31% within this brief period, followed by Continental from DAX with a respectable gain of 20%. The third top stock is the Spanish telecommunications provider Telefonica, which led the portfolio for a long time, with now +17%.
But another piece of news might be even more important than the frontrunners' performance: without exception all stocks in the portfolio developed positively, which means they show an absolute gain in value. They therefore comply with Warren Buffet's first and foremost law: "Don't lose money!"
Compared to the best internationally investing stock funds, the portfolio takes the sensational 14th place among more than 1,500 internationally investing stock funds. And please note: the Leading- Invest portfolio accomplished this without intervention by any funds manager whatsoever. This is the result of investment, not speculation or trading.
In a market situation that cannot be termed particularly promising - marked in Germany by DAX records around 9,000 points, which usually lead to profit takings and limp value growth, and on an international level by the imminent danger of war in the Middle East surrounding the Syrian crisis as well as a two-week budget impasse in the US threatening its liquidity, not to mention the repeated flare-ups of smaller and larger Euro crises - the portfolio developed simply brilliantly.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.